# Ticagrelor in Human Endotoxemia Response to Human Endotoxemia

> **NCT02612480** · NA · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 40 (actual)

## Conditions studied

- Endotoxemia

## Interventions

- **DRUG:** ticagrelor
- **DRUG:** Clopidogrel
- **DRUG:** Acetylsalicylic acid lysinate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02612480
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2015-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02612480

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02612480, "Ticagrelor in Human Endotoxemia Response to Human Endotoxemia". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02612480. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*